Astria Therapeutics
ATXS
ATXS
61 hedge funds and large institutions have $32M invested in Astria Therapeutics in 2021 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 21 increasing their positions, 18 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
0% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 15
2% less funds holding
Funds holding: 62 → 61 (-1)
Holders
61
Holding in Top 10
–
Calls
$3.82M
Puts
$1.36M
Top Buyers
| 1 | +$5.59M | |
| 2 | +$3.74M | |
| 3 | +$2.24M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$2.11M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
+$586K |
Top Sellers
| 1 | -$1.5M | |
| 2 | -$1.12M | |
| 3 | -$434K | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$402K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$272K |